HFA
IMGN

Hoover Financial Advisors’s Immunogen Inc IMGN Stock Holding History

Hoover Financial Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$4K Hold
660
– – ﹤0.01% 566
2021
Q1 		$5K Hold
660
– – ﹤0.01% 497
2020
Q4 		$5K Buy
+660
New +$3.85K ﹤0.01% 464
2020
Q3 		– Sell
-660
Closed -$3K – 497
2020
Q2 		$3K Buy
+660
New +$2.81K ﹤0.01% 436

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Hoover Financial Advisors's IMGN Position: Q2 2021 in Review

Hoover Financial Advisors held its Immunogen Inc (IMGN) position steady in Q2 2021 at 660 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #566.

Hoover Financial Advisors first reported a position in IMGN in Q2 2020 and has held it in 4 quarters since. The position peaked at $5K in Q1 2021. 214 funds tracked by Wall St. Rank hold IMGN as of Q2 2021.

  • Hoover Financial Advisors held 660 shares of Immunogen Inc worth $4K as of Q2 2021.
  • Hoover Financial Advisors left its Immunogen Inc share count unchanged in Q2 2021.
  • Immunogen Inc made up ﹤0.01% of Hoover Financial Advisors's portfolio in Q2 2021, its #566 holding.
  • Hoover Financial Advisors first reported a position in Immunogen Inc in Q2 2020 and has held it in 4 quarters since.
  • Hoover Financial Advisors's Immunogen Inc position peaked at $5K in Q1 2021.
  • 214 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.